TD Asset Management’s Sana Biotechnology SANA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $844K | Hold |
309,034
| – | – | ﹤0.01% | 1082 |
|
|
2025
Q1 | $519K | Sell |
309,034
-95,314
| -24% | -$160K | ﹤0.01% | 1144 |
|
|
2024
Q4 | $659K | Hold |
404,348
| – | – | ﹤0.01% | 1154 |
|
|
2024
Q3 | $1.73M | Hold |
404,348
| – | – | ﹤0.01% | 1083 |
|
|
2024
Q2 | $2.21M | Sell |
404,348
-116,764
| -22% | -$638K | ﹤0.01% | 963 |
|
|
2024
Q1 | $5.21M | Buy |
521,112
+158,460
| +44% | +$1.58M | ﹤0.01% | 769 |
|
|
2023
Q4 | $1.48M | Hold |
362,652
| – | – | ﹤0.01% | 1094 |
|
|
2023
Q3 | $1.4M | Buy |
362,652
+181,326
| +100% | +$702K | ﹤0.01% | 1056 |
|
|
2023
Q2 | $1.08M | Buy |
181,326
+47,100
| +35% | +$281K | ﹤0.01% | 1114 |
|
|
2023
Q1 | $439K | Hold |
134,226
| – | – | ﹤0.01% | 1285 |
|
|
2022
Q4 | $530K | Buy |
134,226
+12,200
| +10% | +$48.2K | ﹤0.01% | 1278 |
|
|
2022
Q3 | $681K | Buy |
122,026
+29,000
| +31% | +$162K | ﹤0.01% | 1244 |
|
|
2022
Q2 | $598K | Buy |
93,026
+44,800
| +93% | +$288K | ﹤0.01% | 1263 |
|
|
2022
Q1 | $398K | Buy |
48,226
+12,500
| +35% | +$103K | ﹤0.01% | 1364 |
|
|
2021
Q4 | $553K | Hold |
35,726
| – | – | ﹤0.01% | 1370 |
|
|
2021
Q3 | $805K | Hold |
35,726
| – | – | ﹤0.01% | 1303 |
|
|
2021
Q2 | $582K | Hold |
35,726
| – | – | ﹤0.01% | 1362 |
|
|
2021
Q1 | $1.2M | Buy |
+35,726
| New | +$1.2M | ﹤0.01% | 1229 |
|